Published in Cell on September 06, 1991
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell (2015) 5.10
The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J Exp Med (1992) 2.13
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A (2001) 1.92
Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J Exp Med (1993) 1.62
LAG-3 in Cancer Immunotherapy. Curr Top Microbiol Immunol (2011) 1.58
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med (1992) 1.48
Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry. J Virol (1996) 1.39
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med (1994) 1.20
Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Proc Natl Acad Sci U S A (1997) 1.14
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
A computer screening approach to immunoglobulin superfamily structures and interactions: discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics. Proc Natl Acad Sci U S A (1997) 1.11
Different extracellular domains of the neural cell adhesion molecule (N-CAM) are involved in different functions. J Cell Biol (1992) 1.08
Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding. Proc Natl Acad Sci U S A (1993) 1.07
Identification of a ligand-binding site in an immunoglobulin fold domain of the Saccharomyces cerevisiae adhesion protein alpha-agglutinin. Mol Biol Cell (1996) 1.05
The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model. Proc Natl Acad Sci U S A (1994) 1.05
Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J (1994) 1.04
Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A (1992) 1.04
Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1 beta. Clin Exp Immunol (1995) 1.04
Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2. J Exp Med (1993) 1.01
Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: identification of a human CD4 enhancer. J Exp Med (1993) 0.93
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci U S A (1993) 0.86
HLA-DR polymorphism affects the interaction with CD4. J Exp Med (1995) 0.84
CD4 promoter transactivation by human herpesvirus 6. J Virol (1998) 0.84
CD4-mediated enhancement or inhibition of T cell activation does not require the CD4:p56lck association. J Exp Med (1994) 0.81
Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4. J Virol (1996) 0.79
A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo. Infect Immun (1997) 0.79
Mechanism for the T4 lymphopenia of AIDS. Proc Natl Acad Sci U S A (1993) 0.79
An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes. Clin Exp Immunol (1995) 0.78
CD4 on the road to coreceptor status. J Immunol (2010) 0.75
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (1998) 24.69
The antigenic structure of the HIV gp120 envelope glycoprotein. Nature (1998) 12.44
A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science (1998) 8.36
Structural basis of cell-cell adhesion by cadherins. Nature (1995) 6.56
Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (1995) 6.16
Structural analysis of substrate binding by the molecular chaperone DnaK. Science (1996) 6.13
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature (1994) 5.68
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure (2000) 5.57
Stereochemically restrained refinement of macromolecular structures. Methods Enzymol (1985) 4.93
Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A (1993) 4.53
Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44
The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein. Nature (1984) 4.05
Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein. Science (1990) 3.77
Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science (1992) 3.66
Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol (2000) 3.52
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med (2001) 3.44
Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med (1992) 3.40
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J Virol (1996) 3.39
Structural basis of the redox switch in the OxyR transcription factor. Cell (2001) 3.32
Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J Virol (1997) 3.29
Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature (1992) 3.19
Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infect Immun (1998) 2.98
Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature (1996) 2.94
Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J Biol Chem (1999) 2.85
Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. J Mol Biol (1987) 2.79
A structural superfamily of growth factors containing a cystine knot motif. Cell (1993) 2.71
Structures of an MHC class II molecule with covalently bound single peptides. Science (1996) 2.58
Structure-function analysis of cell adhesion by neural (N-) cadherin. Neuron (1998) 2.57
Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection. Proc Natl Acad Sci U S A (1997) 2.54
p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J (2001) 2.45
Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science (1991) 2.44
Crystal structure of a novel human peroxidase enzyme at 2.0 A resolution. Nat Struct Biol (1998) 2.38
Dimeric association and segmental variability in the structure of human CD4. Nature (1997) 2.35
HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med (1990) 2.30
Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science (1997) 2.27
Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron (1996) 2.25
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure (1995) 2.20
HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol (1989) 2.11
Characterization and crystallization of core streptavidin. J Biol Chem (1987) 2.09
Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. Hum Immunol (1991) 2.06
Direct phase determination based on anomalous scattering. Methods Enzymol (1985) 2.02
Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci U S A (1997) 1.99
Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev (2001) 1.94
Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol Cell Biol (1996) 1.90
Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. Structure (1994) 1.87
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84
The MHC-binding and gp120-binding functions of CD4 are separable. Science (1989) 1.77
Structural interactions of fibroblast growth factor receptor with its ligands. Proc Natl Acad Sci U S A (2000) 1.76
Crystal structure of a functional unit from Octopus hemocyanin. J Mol Biol (1998) 1.71
Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature (1998) 1.71
Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A (1991) 1.71
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution. Cell (1992) 1.70
Structural and mutational analysis of the PhoQ histidine kinase catalytic domain. Insight into the reaction mechanism. J Biol Chem (2001) 1.67
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture. J Exp Med (1981) 1.66
Structure of the UmuD' protein and its regulation in response to DNA damage. Nature (1996) 1.66
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin Infect Dis (2012) 1.62
Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med (1986) 1.61
Protein structure refinement: Streptomyces griseus serine protease A at 1.8 A resolution. J Mol Biol (1979) 1.60
Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity (1998) 1.58
HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ (2002) 1.54
Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J Immunol (1990) 1.53
Radiation damage in protein crystallography. J Mol Biol (1976) 1.52
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Oncogene (2000) 1.50
Crystallization of a fragment of human fibronectin: introduction of methionine by site-directed mutagenesis to allow phasing via selenomethionine. Proteins (1994) 1.49
Structure of the biotinyl domain of acetyl-coenzyme A carboxylase determined by MAD phasing. Structure (1995) 1.49
The effect of poly(ADP-ribosyl)ation on native and H1-depleted chromatin. A role of poly(ADP-ribosyl)ation on core nucleosome structure. J Biol Chem (1989) 1.46
Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatase mutant of the human pathogen Candida albicans. Mol Biol Cell (1997) 1.45
Influence of solvent accessibility and intermolecular contacts on atomic mobilities in hemerythrins. Proc Natl Acad Sci U S A (1985) 1.44
Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes. Eur J Immunol (1993) 1.42
Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure (1995) 1.42
Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci U S A (1996) 1.41
Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol (2000) 1.40
Crystal structure of Clostridium acidi-urici ferredoxin at 5-A resolution based on measurements of anomalous X-ray scattering at multiple wavelengths. J Biol Chem (1988) 1.39
Highly ordered crystals of the plant seed protein crambin. J Mol Biol (1979) 1.37
Crystal structure of mouse H2-M. Immunity (1998) 1.34
Structure of interleukin 1 alpha at 2.7-A resolution. Biochemistry (1990) 1.34
A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem (1991) 1.30
Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. J Biol Chem (1986) 1.30
MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family. Structure (1997) 1.30
Identification and characterization of zinc binding sites in protein kinase C. Science (1991) 1.30
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol (2005) 1.29
Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem (1996) 1.27
Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets. Eur J Immunol (1982) 1.26
Mutations in the C-terminal fragment of DnaK affecting peptide binding. Proc Natl Acad Sci U S A (1996) 1.24
Structural heterogeneity in protein crystals. Biochemistry (1986) 1.22
Expression, purification, and crystallization of natural and selenomethionyl recombinant ribonuclease H from Escherichia coli. J Biol Chem (1990) 1.18
In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus. J Biol Chem (2001) 1.17
An Epstein-Barr virus-associated superantigen. J Exp Med (1996) 1.17
Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J Biol Chem (1995) 1.17
Refinement at 1.4 A resolution of a model of erabutoxin b: treatment of ordered solvent and discrete disorder. Acta Crystallogr A (1988) 1.17
Differentiation in vitro of Lyt 2+ thymocytes from embryonic Lyt 2- precursors. Nature (1983) 1.16
Structure of the active core of human stem cell factor and analysis of binding to its receptor kit. EMBO J (2000) 1.16
Footprint analysis of replicating murine leukemia virus reverse transcriptase. Science (1995) 1.13
Exploration of disorder in protein structures by X-ray restrained molecular dynamics. Proteins (1991) 1.13
Radioimmunoassay of atrial natriuretic factor: human plasma levels. Biochem Biophys Res Commun (1985) 1.13